Beta Bionics (BBNX) Securities Investigation: Johnson Fistel Reviews Investor Losses Following Slower New Patient Start Growth

SAN DIEGO, June 05, 2026 (GLOBE NEWSWIRE) — Johnson Fistel, PLLP is investigating potential securities law violations on behalf of investors of Beta Bionics, Inc. (NASDAQ: BBNX). The investigation concerns whether Beta Bionics or certain of its executive officers made false or misleading statements, or failed to disclose material information, concerning the Company’s growth trends, new patient starts, business outlook, and related operating metrics.

Source: https://www.globenewswire.com/news-release/2026/06/05/3307514/0/en/Beta-Bionics-BBNX-Securities-Investigation-Johnson-Fistel-Reviews-Investor-Losses-Following-Slower-New-Patient-Start-Growth.html